The new world-first trial increasing life expectancy of kids with DIPG

There’s been a major step forward in treating one of the deadliest childhood cancers, thanks to a groundbreaking discovery by Hunter researchers.

A University of Newcastle team has now started a world-first trial of a drug combination, shown to double the life expectancy of some patients.

But many families are calling on more government funding to support it.